Dr. Nirav Shah, MD
Claim this profileMedical College of Wisconsin
Studies Lymphoma
Studies Coronavirus
18 reported clinical trials
24 drugs studied
Area of expertise
1Lymphoma
CD19 positive
Philadelphia chromosome positive
MYC positive
2Coronavirus
SARS-CoV-2
PCR
collection
Affiliated Hospitals
Clinical Trials Nirav Shah, MD is currently running
CAR T-Cell Therapy + Ibrutinib
for Chronic Lymphocytic Leukemia
This is a phase I/II study to evaluate the feasibility, safety and preliminary antitumor efficacy of rapcabtagene autoleucel (also known as YTB323). Rapcabtagene autoleucel will be investigated in combination with ibrutinib in chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) and as single agent in diffuse large B-cell lymphoma (3L+ DLBCL), adult acute lymphoblastic leukemia (ALL) and 1st Line High Risk Large B-Cell Lymphoma (1L HR LBCL).
Recruiting1 award Phase 1 & 212 criteria
Mirikizumab
for Ulcerative Colitis
This trial is testing mirikizumab, a medication for people with severe ulcerative colitis. It aims to see if the drug can reduce gut inflammation by blocking a protein that causes it. The study will last several years. Mirikizumab has shown positive results in early tests for ulcerative colitis.
Recruiting2 awards Phase 31 criteria
More about Nirav Shah, MD
Clinical Trial Related4 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Nirav Shah, MD has experience with
- Placebo
- Montelukast
- T-Guard
- Ruxolitinib
- KPG-818
- Ivermectin
Breakdown of trials Nirav Shah, MD has run
Lymphoma
Non-Hodgkin's Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nirav Shah, MD specialize in?
Nirav Shah, MD focuses on Lymphoma and Coronavirus. In particular, much of their work with Lymphoma has involved CD19 positive patients, or patients who are Philadelphia chromosome positive.
Is Nirav Shah, MD currently recruiting for clinical trials?
Yes, Nirav Shah, MD is currently recruiting for 7 clinical trials in Milwaukee Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Nirav Shah, MD has studied deeply?
Yes, Nirav Shah, MD has studied treatments such as Placebo, Montelukast, T-Guard.
What is the best way to schedule an appointment with Nirav Shah, MD?
Apply for one of the trials that Nirav Shah, MD is conducting.
What is the office address of Nirav Shah, MD?
The office of Nirav Shah, MD is located at: Medical College of Wisconsin, Milwaukee, Wisconsin 53226 United States. This is the address for their practice at the Medical College of Wisconsin.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.